What is the likely diagnosis and treatment for an itchy rash in a healthy 40‑year‑old woman who just returned from Mexico and had a recent cold?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Likely Diagnosis and Management

This is most likely cutaneous larva migrans (CLM), a self-limited parasitic skin infection acquired from contaminated sand or soil in Mexico, and should be treated with a single oral dose of ivermectin 200 mcg/kg or albendazole 400 mg daily for 3 days. 1

Clinical Reasoning

Why Cutaneous Larva Migrans is Most Likely

  • CLM presents with a characteristic itchy, serpiginous (snake-like) rash that migrates 1-2 cm per day, caused by dog or cat hookworm larvae penetrating the skin 1, 2
  • Mexico is endemic for CLM, as the condition has worldwide distribution with predominance in warmer, tropical and subtropical regions 1, 2
  • The timing fits: CLM typically appears within days of exposure to contaminated beach sand or soil 1
  • The "cold" during travel is likely unrelated to the rash, as CLM is not associated with upper respiratory symptoms 1

Key Diagnostic Features to Confirm

  • Look for raised, erythematous, serpiginous (winding/snake-like) tracks on the skin, most commonly on feet, legs, buttocks, or hands 1
  • Ask about walking barefoot on beaches or sitting on sand in Mexico 1
  • The rash should be intensely pruritic (itchy) 1, 3
  • Diagnosis is entirely clinical—no laboratory testing is required 1
  • Peripheral eosinophilia may be present but is not necessary for diagnosis 1

First-Line Treatment Options

Choose either of these equally effective regimens:

  • Ivermectin 200 mcg/kg as a single oral dose (cure rates 95-100%) 1

    • Preferred for convenience (single dose)
    • Well-tolerated with minimal side effects 1
  • Albendazole 400 mg orally once daily for 3 days 1

    • Alternative first-line option with excellent efficacy 1
    • May extend to 7 days if multiple or extensive lesions 1

Critical Management Pitfalls

  • Do not confuse persistent itching with treatment failure: Pruritus can persist for several days after successful parasite eradication due to ongoing inflammatory response 1
  • Distinguish CLM from human hookworm infection (Ancylostoma duodenale, Necator americanus), which causes minimal skin symptoms but proceeds to systemic infection requiring different management 1, 2
  • The zoonotic hookworm larvae causing CLM remain trapped in the epidermis and cannot complete their life cycle in humans, whereas human hookworm larvae migrate internally 2

Special Population Considerations

  • Pregnancy: Ivermectin has shown no teratogenicity in limited human data, though caution is warranted; albendazole should be avoided in first trimester 1
  • Breastfeeding: Both medications appear compatible based on low excretion into breast milk 1
  • No dose adjustment needed for renal impairment, but safety of multiple ivermectin doses in severe liver disease is not established 1

Alternative Diagnoses to Briefly Consider

While CLM is most likely, briefly assess for:

  • Cercarial dermatitis (swimmer's itch): Presents within hours of freshwater exposure with itchy maculopapular rash, but does not have the characteristic serpiginous pattern 4
  • Drug reaction: The recent "cold" may have been treated with medications causing pruritus, though this typically lacks the migratory serpiginous pattern 5
  • Schistosomiasis: Can cause itchy rash but typically presents with systemic symptoms (fever, headache, cough) and requires freshwater exposure 4

Expected Clinical Course

  • The rash is self-limited and will resolve spontaneously in weeks to months without treatment, but treatment dramatically shortens duration and relieves symptoms 1
  • Symptomatic improvement typically occurs within 48-72 hours of treatment 1
  • Reassure the patient this is not dangerous and does not lead to systemic infection 2

References

Guideline

Treatment of Cutaneous Larva Migrans

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Cutaneous Larva Migrans Epidemiology and Clinical Distinctions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tropical parasitic itch in returned travellers and immigrants from endemic areas.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2022

Guideline

Diagnosis and Management of Non-Blanching Rash on Lower Limbs After Mangrove Forest Travel

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.